Why the Middle East and Africa Pharmacogenetics Testing in...

ha aggiunto una foto Altre informazioni

2025-12-23 08:37:25

Why the Middle East and Africa Pharmacogenetics Testing in Psychiatry/Depression Market Is Gaining Clinical Attention

"In-Depth Study on Executive Summary Middle East and Africa Pharmacogenetics Testing in Psychiatry/Depression Market Size and Share CAGR Value Data Bridge Market Research analyzes that the Middle East & Africa pharmacogenetics testing in psychiatry/depression market is expected to reach the value of USD 49.64 million by 2029, at a CAGR of 7.1% during the forecast period....

0 Commenti 0 condivisioni 12 Views 0 Anteprima